Publication | Open Access
A randomized controlled trial of lamivudine to treat acute hepatitis B
202
Citations
11
References
2006
Year
Though lamivudine causes a greater decrease in levels of HBV DNA, it does not cause significantly greater biochemical and clinical improvement as compared to placebo in patients with acute hepatitis B.
| Year | Citations | |
|---|---|---|
Page 1
Page 1